TargetMol

L 659989

Product Code:
 
TAR-T24314
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T24314-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T24314-50mg50mg£1,661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T24314-100mg100mg£2,079.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
L 659989 is an antagonist of the Platelet-activating factor receptor.
CAS:
129314-27-8
Formula:
C24H32O8S
Molecular Weight:
480.57
Purity:
0.98
SMILES:
CCCOc1c(OC)cc(cc1S(C)(=O)=O)C1CCC(O1)c1cc(OC)c(OC)c(OC)c1

References

1. Birk-S?rensen L, Kerrigan CL, Wang C. Platelet activating factor antagonism in pure skin flaps exposed to ischaemia-reperfusion injury. Scand J Plast Reconstr Surg Hand Surg. 1999 Jun;33(2):155-61. PubMed PMID: 10450571. 2. G?mez-Mu?oz A, O'Brien L, Steinbrecher UP. The platelet-activating factor receptor antagonist L-659,989 inhibits phospholipase D activity. Biochim Biophys Acta. 1999 May 18;1438(2):247-52. PubMed PMID: 10320807. 3. Stotland MA, Kerrigan CL. The role of platelet-activating factor in musculocutaneous flap reperfusion injury. Plast Reconstr Surg. 1997 Jun;99(7):1989-99; discussion 2000-1. PubMed PMID: 9180723. 4. Herbertson MJ, Werner HA, Walley KR. Platelet-activating factor antagonism improves ventricular contractility in endotoxemia. Crit Care Med. 1997 Feb;25(2):221-6. PubMed PMID: 9034254.